These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 696477)

  • 1. Peripheral nerves as target tissue of the immune response in EAN. A neurochemical and morphological study.
    Molnár GK; Riekkinen PJ
    Adv Exp Med Biol; 1978; 100():471-7. PubMed ID: 696477
    [No Abstract]   [Full Text] [Related]  

  • 2. Guillan-Barré syndrome. Neurochemical and ultrastructural study.
    Arstila AU; Riekkinen PJ; Rinne UK; Pelliniemi TT; Nevalainen T
    Eur Neurol; 1971; 5(5):257-69. PubMed ID: 5133548
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental allergic neuritis induced by galactocerebroside.
    Saida T; Saida K; Silberberg DH; Brown MJ
    Ann Neurol; 1981; 9 Suppl():87-101. PubMed ID: 7224618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinases in inflammatory demyelinating disease.
    Bever CT; Whitaker JN
    Springer Semin Immunopathol; 1985; 8(3):235-50. PubMed ID: 3901368
    [No Abstract]   [Full Text] [Related]  

  • 5. Histochemical study of the implication of certain nervous tissue hydrolases in effort and exhaustion.
    Gabrielescu E; Bordeianu A
    Acta Histochem; 1968; 31(2):319-29. PubMed ID: 4979191
    [No Abstract]   [Full Text] [Related]  

  • 6. Multifocal demyelinating motor neuropathy: pathologic evidence of 'inflammatory demyelinating polyradiculoneuropathy'.
    Oh SJ; Claussen GC; Odabasi Z; Palmer CP
    Neurology; 1995 Oct; 45(10):1828-32. PubMed ID: 7477976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trigeminal nerve hypertrophy in chronic inflammatory demyelinating polyradiculoneuropathy.
    Guibord N; Chalk C; Wein F; Richardson J; Snipes GJ; Del Carpio R
    Neurology; 1998 Nov; 51(5):1459-62. PubMed ID: 9818882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fulminant case of Guillain-Barré syndrome: topographic and fibre size related analysis of demyelinating changes.
    Kanda T; Hayashi H; Tanabe H; Tsubaki T; Oda M
    J Neurol Neurosurg Psychiatry; 1989 Jul; 52(7):857-64. PubMed ID: 2769280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy.
    Leppert D; Hughes P; Huber S; Erne B; Grygar C; Said G; Miller KM; Steck AJ; Probst A; Fuhr P
    Neurology; 1999 Jul; 53(1):62-70. PubMed ID: 10408538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical correlations in autoimmune target tissue lesions of GBS and EAN.
    Molnãr GK; Riekkinen PJ
    Prog Clin Biol Res; 1980; 39():357-67. PubMed ID: 7403187
    [No Abstract]   [Full Text] [Related]  

  • 11. Inflammatory-demyelinating polyneuropathies.
    Feasby TE
    Neurol Clin; 1992 Aug; 10(3):651-70. PubMed ID: 1323748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peptide peptidohydrolase activity of the peripheral nerve in secondary myelinic degeneration induced with organophosphoric substances (DFP)].
    Faina L; Fattori G; Pirotta M; Porcellati G
    Acta Neurol (Napoli); 1971; 26(3):243-5. PubMed ID: 4328667
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic inflammatory demyelinating polyradiculoneuropathy: unusual clinical features and therapeutic responses.
    Midroni G; Dyck PJ
    Neurology; 1996 May; 46(5):1206-12. PubMed ID: 8628454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophic neuritis due to chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a postmortem pathological study.
    Matsuda M; Ikeda S; Sakurai S; Nezu A; Yanagisawa N; Inuzuka T
    Muscle Nerve; 1996 Feb; 19(2):163-9. PubMed ID: 8559164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inflammatory demyelinating polyneuropathy.
    Rizzuto N; Simonati A
    Int J Tissue React; 1985; 7(6):521-6. PubMed ID: 4086221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental immunology of Guillain-Barré syndrome.
    Abramsky O; Steiner I
    Int J Neurol; 1981; 15(3-4):301-13. PubMed ID: 6927600
    [No Abstract]   [Full Text] [Related]  

  • 17. P2-reactive T cells in inflammatory demyelination of the peripheral nerve.
    Rostami AM
    J Infect Dis; 1997 Dec; 176 Suppl 2():S160-3. PubMed ID: 9396703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyradiculoneuropathy accompanying procainamide-induced lupus erythematosus: evidence for drug-induced enhanced sensitization to peripheral nerve myelin.
    Sahenk Z; Mendell JR; Rossio JL; Hurtubise P
    Ann Neurol; 1977 Apr; 1(4):378-84. PubMed ID: 617255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve root hypertrophy as the cause of lumbar stenosis in chronic inflammatory demyelinating polyradiculoneuropathy.
    Goldstein JM; Parks BJ; Mayer PL; Kim JH; Sze G; Miller RG
    Muscle Nerve; 1996 Jul; 19(7):892-6. PubMed ID: 8965844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into Campylobacter jejuni-induced Guillain-Barré syndrome from the Lewis rat model of experimental allergic neuritis.
    Vriesendorp FJ
    J Infect Dis; 1997 Dec; 176 Suppl 2():S164-8. PubMed ID: 9396704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.